Application of positron emission tomography-computed tomography in lymphoma: reports from the 56th American Society of Hematology annual meeting
10.3760/cma.j.issn.1009-9921.2015.04.002
- VernacularTitle:PET-CT在淋巴瘤中的应用:第56届美国血液学会年会报道
- Author:
Hui LIU
;
Chunli ZHANG
- Publication Type:Journal Article
- Keywords:
Lymphoma;
Positron emission tomography-computed tomography;
American Society of Hematology annual meeting
- From:
Journal of Leukemia & Lymphoma
2015;24(4):197-199
- CountryChina
- Language:Chinese
-
Abstract:
Positron emission tomography-computed tomography (PET-CT) is widely used in the diagnosis and grading of FDG-uptake lymphoma,particularly in the extranodal lesions.Baseline PET-CT improves the accuracy of subsequent response assessment.Focal FDG uptake within the bone or bone marrow is highly sensitive for involvement in Hodgkin' s lymphoma (HL) and diffuse large B-cell lymphoma (DLBCL) and is better than bone marrow biopsy.Many international trials suggest that interim scan is prognostic,but not proven as a method to guide therapy.A negative PET-CT scan at the end of therapy is the best predictor of a good outcome.However,surveillance PET-CT scan should not be done routinely.
